Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > IL Providers > Urologists

Dr. Paul M. Yonover, MD, FACS

(326 Ratings)

Specializes in: Urology (Urinary Tract Disease)

Mount Sinai School of Medicine

Professional interests include: laparoscopic surgery, benign prostatic hyperplasia (enlarged prostate), kidney problems, and more.

1011 W Wellington Avenue Suite 200
Chicago, IL 60657

(847) 986-3030

Dr. Paul M. Yonover, MD, FACS is an urologist in Chicago, IL specializing in urology (urinary tract disease). He graduated from Mount Sinai School of Medicine. Dr. Paul M. Yonover, MD, FACS is affiliated with Advocate Health Care, Northwestern Medicine, UroPartners, Ascension, Ascension Saint Joseph - Chicago and UroPartners.

Office Locations

Northwestern Medicine

1011 W Wellington Avenue Suite 200
Chicago, IL 60657

(847) 986-3030

(773) 281-1029

open_in_new

Advocate Health Care

1051 Perimeter Drive Suite 150
Schaumburg, IL 60173

(847) 823-3185

(847) 823-3188

open_in_new

Advocate Health Care

2235 Enterprise Drive Suite 3510
Westchester, IL 60154

(847) 957-4670

(847) 957-4678

open_in_new

Advocate Health Care

2600 Patriot Boulevard Suite J
Glenview, IL 60026

(773) 281-1011

(773) 281-1029

open_in_new

Advocate Health Care

350 S Northwest Highway Suite 106
Park Ridge, IL 60068

(847) 470-1500

(847) 470-1550

open_in_new

Some issues Dr. Paul M. Yonover, MD, FACS can help you with:

Benign Prostatic Hyperplasia (Enlarged Prostate)

Benign prostatic hyperplasia (BPH) is a noncancerous condition in which the prostate gland becomes enlarged. BPH affects about half of men between the ages of 50 and 60, and approximately 80% of men over 80. As the prostate grows in size, it can press down on the tube where urine flows out of the body (the urethra) and cause urinary problems.

Medication can relieve mild to moderate symptoms of BPH, such as frequent urination, incomplete bladder emptying, a weak urine stream, and straining while urinating. However, other forms of treatment may be more appropriate if an individual has pain with urination, frequent urinary tract infections, or is unable to urinate. The size of the prostate and the severity of their symptoms will determine the type of treatment they need. If the prostate is not very large, doctors will likely recommend a transurethral procedure. This minimally invasive technique involves the insertion of a scope into the urethra. The most common transurethral procedures for BPH are:

Transurethral incision of the prostate or TUIP, where the surgeon uses the scope to make small cuts in the area of the prostate that meets the bladder. These cuts will open up the pathway for urine and allow it to flow with more ease.
Transurethral needle ablation or TUNA, where needles are inserted through the scope and into the prostate. The needles use radiofrequency waves to destroy excess prostate tissue.
Laser prostate ablation, where lasers pass through the scope to melt away the part of the prostate causing urine blockage.
Transurethral resection of the prostate or TURP, where the inside of the prostate is trimmed and removed one tiny piece at a time using the scope.

If the prostate is too big for a transurethral procedure, an individual may need a simple prostatectomy, which can be done in one of three ways: laparoscopic, robotic, or open. During a laparoscopic simple prostatectomy, a surgeon makes several small incisions on the belly. Then they insert a long tube with a camera into one of the cuts and surgical instruments into the others. Using the camera to see inside the belly, they carefully removes the enlarged part of the prostate. Robotic simple prostatectomy uses the same techniques as the laparoscopic method, but the surgery is done with the help of a robot. For men with very large prostates, open simple prostatectomy may be the best treatment option. This surgery differs from the other approaches in that it requires a much larger incision.

Most transurethral treatments for BPH, like TUIP, TUNA, and laser prostate ablation, are done in the doctor's office or outpatient surgery center. TURP and simple prostatectomy, however, need to be performed in the hospital and require an average stay of one to three days. Patients should wait a week before doing any strenuous activities after a TUIP, TUNA, or laser prostate ablation, and about four to six weeks after a TURP or simple prostatectomy. Although these treatments improve BPH symptoms for most patients, it is important to be aware of the risks involved, such as urine control issues, tightening of the urethra, and erectile dysfunction.

Kidney Stones

Kidney stones are hard deposits that form in the kidneys, made up of minerals that are normally present in urine. They can vary in size, from as small as a grain of sand to as large as a nickel, occasionally even larger. Sometimes they lodge in the kidney, and sometimes they break free and make their way out through the urinary tract, which can be extremely painful.

Kidney stones can be smooth or jagged and are yellow to brown in color. They are mostly comprised of the minerals calcium, oxalate, and phosphorus. Examining the stones to see what they are made of can show what caused the stone to be formed in the first place. For example, a stone made of mostly calcium, which is the most common type, can happen any time the urine becomes too concentrated due to dehydration or a blockage in the kidney. A uric acid stone forms when acid levels in the urine get too high, usually due to excessive consumption of animal protein such as meat and fish. A struvite stone is a sign of certain infections, and a cystine stone can be due to a genetic disorder that raises the risk of kidney stones.

The most common symptom of kidney stones is pain, either in the back or lower abdomen, or severe pain when urinating. There may also be blood in the urine. Treatment for kidney stones depends on how large the stone is. Very small stones can pass out of the body on their own, and they do not require treatment other than drinking adequate water and taking pain killers. Larger stones need to be broken apart and removed. The main treatment options are:

Shock wave lithotripsy, which uses sound wave vibrations to break apart the stone
Percutaneous nephrolithotomy, or the use of a very tiny tool (like a wire inserted through the back) to break apart and remove the stone
Ureteroscopy, a thin tube inserted through the urethra and bladder to the stone, where tiny tools can grasp the stone and remove

People who have had one kidney stone are at risk of developing another. To reduce this risk, patients are given instructions specific to the type of stone they developed. Generally the instructions will include drinking more water to dilute the urine, but it may also involve lowering sodium intake or eating less meat.

Laparoscopic Surgery

Laparoscopic surgery is a kind of minimally invasive surgery using a thin, narrow tube called a laparoscope. Usually performed on the abdomen or the pelvic region, the surgeon makes a few very small incisions instead of one large one.

During the procedure, the surgeon inserts the laparoscope, which contains a light and camera that allows the surgeon to see what is happening inside the body. Then tiny tools are placed through the small openings and used to perform the surgery.

The most common laparoscopic surgery is gallbladder removal, but laparoscopic surgery may also be used for the removal of a kidney or appendix, to treat certain cysts and tumors, for bariatric surgery, for some GERD treatments, or for hernia repairs, among others.

Because laparoscopic surgery only uses a few tiny incisions, the scars are minimal and recovery is easier than with open surgery.

In The News

“said Dr. Paul Yonover, a Chicago-based urologist, who specializes in prostate cancer.”—"'Strongest in the broken places': Joe and Jill Biden say thanks amid cancer diagnosis", ABC7 News, May 2025

Noteworthy Medicare Patient Procedures Performed by Dr. Paul M. Yonover, MD, FACS in 2023

Click on any procedure below to see further details on volume and pricing among Medicare patients.

Top 25%

By Volume:

blood draw

creatinine test

minimally invasive procedures

phlebotomy for lab tests

In 2012, Dr. Paul M. Yonover, MD, FACS performed more blood draw, creatinine test, minimally invasive procedures, and phlebotomy for lab tests procedures for Medicare patients than 75% of providers in related specialties within Illinois.

Medicare Procedure and Patient Information

2012 Medicare Procedure Volume

The top procedures that Dr. Paul M. Yonover, MD, FACS treated as an urologist in Chicago, IL during 2012 were lab tests, urologic procedures, blood draw and minimally invasive procedures.

Volume of procedures performed by Dr. Paul M. Yonover, MD, FACS for Medicare patients.

blood draw	174
catheterization	54
diagnostic procedures	23
doctor visit	639
hospital care	35
inpatient care	35
lab tests	597
marker placement for prostate radiation therapy	11
minimally invasive procedures	115
minor procedures	23
potassium test	18
stent placement (stenting)	18
urologic procedures	326

Medicare Procedure and Patient Information

2013 Medicare Procedure Volume

The top procedures that Dr. Paul M. Yonover, MD, FACS treated as an urologist in Chicago, IL during 2013 were lab tests, urologic procedures, blood draw and minimally invasive procedures.

Volume of procedures performed by Dr. Paul M. Yonover, MD, FACS for Medicare patients.

blood draw	263
diagnostic procedures	21
doctor visit	733
hormone therapy	31
hospital care	57
inpatient care	57
lab tests	826
minimally invasive procedures	83
minor procedures	21
pelvic imaging	25
potassium test	15
ultrasound (sonogram)	25
urologic procedures	271

2013 Medicare Patient Data

Information about Medicare patients treated by Dr. Paul M. Yonover, MD, FACS.

**Gender**
Male	286
Female	42

**Ethnicity**
Non-Hispanic White	208
Black	70
Hispanic	30
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	185
From 75 to 84	81
85 and over	31
Less than 65	31

Conditions of Medicare patients treated by Dr. Paul M. Yonover, MD, FACS in 2013

Hypertension	67
High Cholesterol	50
Stroke	5
Ischemic Heart Disease	33
Depression	19
Chronic Kidney Disease	29
Asthma	5
Osteoperosis	7
Atrial Fibrilation	10
Heart Failure	17
Chronic Obstructive Pulmonary Disease	10
Diabetes	34
Dementia	12
Cancer	33

Medicare Procedure and Patient Information

2014 Medicare Procedure Volume

The top procedures that Dr. Paul M. Yonover, MD, FACS treated as an urologist in Chicago, IL during 2014 were lab tests, urologic procedures, blood draw and minimally invasive procedures.

Volume of procedures performed by Dr. Paul M. Yonover, MD, FACS for Medicare patients.

anorectal procedures	11
blood draw	258
diagnostic procedures	32
doctor visit	792
hormone therapy	37
hospital care	42
inpatient care	42
lab tests	817
minimally invasive procedures	115
minor procedures	21
potassium test	20
stent placement (stenting)	14
urologic procedures	422

2014 Medicare Patient Data

Information about Medicare patients treated by Dr. Paul M. Yonover, MD, FACS.

**Gender**
Male	287
Female	45

**Ethnicity**
Non-Hispanic White	212
Black	62
Hispanic	38
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	179
From 75 to 84	92
85 and over	36
Less than 65	25

Conditions of Medicare patients treated by Dr. Paul M. Yonover, MD, FACS in 2014

Hypertension	62
High Cholesterol	50
Stroke	5
Ischemic Heart Disease	34
Depression	18
Chronic Kidney Disease	30
Asthma	5
Osteoperosis	7
Atrial Fibrilation	12
Heart Failure	18
Chronic Obstructive Pulmonary Disease	11
Diabetes	32
Dementia	13
Cancer	27

Medicare Procedure and Patient Information

2015 Medicare Procedure Volume

The top procedures that Dr. Paul M. Yonover, MD, FACS treated as an urologist in Chicago, IL during 2015 were lab tests, urologic procedures, blood draw and minimally invasive procedures.

Volume of procedures performed by Dr. Paul M. Yonover, MD, FACS for Medicare patients.

blood draw	301
catheterization	46
diagnostic procedures	81
doctor visit	796
hormone therapy	52
hospital care	24
inpatient care	24
lab tests	755
minimally invasive procedures	165
minor procedures	81
potassium test	22
urologic procedures	474

2015 Medicare Patient Data

Information about Medicare patients treated by Dr. Paul M. Yonover, MD, FACS.

**Gender**
Male	680
Female	92

**Ethnicity**
Non-Hispanic White	544
Black	126
Hispanic	64
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	444
From 75 to 84	220
85 and over	70
Less than 65	38

Conditions of Medicare patients treated by Dr. Paul M. Yonover, MD, FACS in 2015

Hypertension	61
High Cholesterol	48
Stroke	5
Ischemic Heart Disease	30
Depression	18
Chronic Kidney Disease	30
Asthma	9
Osteoperosis	6
Atrial Fibrilation	11
Heart Failure	15
Chronic Obstructive Pulmonary Disease	11
Diabetes	28
Dementia	10
Cancer	35

Medicare Procedure and Patient Information

2016 Medicare Procedure Volume

The top procedures that Dr. Paul M. Yonover, MD, FACS treated as an urologist in Chicago, IL during 2016 were urologic procedures, lab tests, minimally invasive procedures and blood draw.

Volume of procedures performed by Dr. Paul M. Yonover, MD, FACS for Medicare patients.

blood draw	221
catheterization	47
diagnostic procedures	104
doctor visit	766
hormone therapy	33
hospital care	26
inpatient care	26
lab tests	360
minimally invasive procedures	239
minor procedures	104
neurostimulation	52
potassium test	24
stent placement (stenting)	22
urologic procedures	447

2016 Medicare Patient Data

Information about Medicare patients treated by Dr. Paul M. Yonover, MD, FACS.

**Gender**
Male	365
Female	53

**Ethnicity**
Non-Hispanic White	290
Black	69
Hispanic	35
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	248
From 75 to 84	110
85 and over	37
Less than 65	23

Conditions of Medicare patients treated by Dr. Paul M. Yonover, MD, FACS in 2016

Hypertension	59
High Cholesterol	45
Stroke	3
Ischemic Heart Disease	28
Depression	18
Chronic Kidney Disease	31
Asthma	11
Osteoperosis	6
Atrial Fibrilation	7
Heart Failure	13
Chronic Obstructive Pulmonary Disease	8
Diabetes	28
Dementia	9
Cancer	35

Medicare Procedure and Patient Information

2017 Medicare Procedure Volume

The top procedures that Dr. Paul M. Yonover, MD, FACS treated as an urologist in Chicago, IL during 2017 were urologic procedures, lab tests, blood draw and minimally invasive procedures.

Volume of procedures performed by Dr. Paul M. Yonover, MD, FACS for Medicare patients.

anorectal procedures	12
blood draw	251
catheterization	28
diagnostic procedures	113
doctor visit	802
hormone therapy	72
hospital care	33
inpatient care	33
lab tests	453
minimally invasive procedures	192
minor procedures	101
potassium test	15
urologic procedures	542

2017 Medicare Patient Data

Information about Medicare patients treated by Dr. Paul M. Yonover, MD, FACS.

**Gender**
Male	428
Female	51

**Ethnicity**
Non-Hispanic White	328
Black	81
Hispanic	36
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	256
From 75 to 84	143
85 and over	54
Less than 65	26

Conditions of Medicare patients treated by Dr. Paul M. Yonover, MD, FACS in 2017

Hypertension	62
High Cholesterol	46
Stroke	4
Ischemic Heart Disease	31
Depression	15
Chronic Kidney Disease	30
Asthma	5
Osteoperosis	5
Atrial Fibrilation	11
Heart Failure	14
Chronic Obstructive Pulmonary Disease	9
Diabetes	25
Dementia	10
Cancer	33

Medicare Procedure and Patient Information

2018 Medicare Procedure Volume

The top procedures that Dr. Paul M. Yonover, MD, FACS treated as an urologist in Chicago, IL during 2018 were urologic procedures, blood draw, minimally invasive procedures and lab tests.

Volume of procedures performed by Dr. Paul M. Yonover, MD, FACS for Medicare patients.

blood draw	271
diagnostic procedures	115
doctor visit	685
hormone therapy	51
hospital care	16
inpatient care	16
lab tests	190
minimally invasive procedures	240
minor procedures	115
neurostimulation	65
urologic procedures	421

2018 Medicare Patient Data

Information about Medicare patients treated by Dr. Paul M. Yonover, MD, FACS.

**Gender**
Male	426
Female	29

**Ethnicity**
Non-Hispanic White	310
Black	75
Hispanic	35
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	243
From 75 to 84	148
85 and over	35
Less than 65	29

Conditions of Medicare patients treated by Dr. Paul M. Yonover, MD, FACS in 2018

Hypertension	60
High Cholesterol	53
Stroke	4
Ischemic Heart Disease	32
Depression	16
Chronic Kidney Disease	27
Asthma	5
Osteoperosis	5
Atrial Fibrilation	10
Heart Failure	12
Chronic Obstructive Pulmonary Disease	9
Diabetes	25
Dementia	6
Cancer	42

Medicare Procedure and Patient Information

2019 Medicare Procedure Volume

The top procedures that Dr. Paul M. Yonover, MD, FACS treated as an urologist in Chicago, IL during 2019 were urologic procedures, lab tests, blood draw and minimally invasive procedures.

Volume of procedures performed by Dr. Paul M. Yonover, MD, FACS for Medicare patients.

blood draw	227
diagnostic procedures	70
doctor visit	663
hormone therapy	26
hospital care	17
inpatient care	17
lab tests	282
minimally invasive procedures	135
minor procedures	70
urologic procedures	410

2019 Medicare Patient Data

Information about Medicare patients treated by Dr. Paul M. Yonover, MD, FACS.

**Gender**
Male	372
Female	44

**Ethnicity**
Non-Hispanic White	281
Black	63
Hispanic	32
Asian	0
Other	25
Native American	0

**Age**
From 65 to 74	233
From 75 to 84	126
85 and over	32
Less than 65	25

Conditions of Medicare patients treated by Dr. Paul M. Yonover, MD, FACS in 2019

Hypertension	62
High Cholesterol	57
Stroke	5
Ischemic Heart Disease	34
Depression	19
Chronic Kidney Disease	26
Asthma	5
Osteoperosis	7
Atrial Fibrilation	9
Heart Failure	13
Chronic Obstructive Pulmonary Disease	14
Diabetes	26
Dementia	8
Cancer	34

Medicare Procedure and Patient Information

2020 Medicare Procedure Volume

The top procedures that Dr. Paul M. Yonover, MD, FACS treated as an urologist in Chicago, IL during 2020 were urologic procedures, lab tests, blood draw and minimally invasive procedures.

Volume of procedures performed by Dr. Paul M. Yonover, MD, FACS for Medicare patients.

blood draw	252
diagnostic procedures	18
doctor visit	734
hormone therapy	45
hospital care	11
inpatient care	11
lab tests	269
minimally invasive procedures	69
minor procedures	18
urologic procedures	395

2020 Medicare Patient Data

Information about Medicare patients treated by Dr. Paul M. Yonover, MD, FACS.

**Gender**
Male	366
Female	40

**Ethnicity**
Non-Hispanic White	266
Black	73
Hispanic	33
Asian	0
Other	20
Native American	0

**Age**
From 65 to 74	222
From 75 to 84	130
85 and over	33
Less than 65	21

Conditions of Medicare patients treated by Dr. Paul M. Yonover, MD, FACS in 2020

Hypertension	60
High Cholesterol	52
Stroke	3
Ischemic Heart Disease	30
Depression	13
Chronic Kidney Disease	26
Asthma	4
Osteoperosis	4
Atrial Fibrilation	8
Heart Failure	14
Chronic Obstructive Pulmonary Disease	9
Diabetes	25
Dementia	7
Cancer	37

Medicare Procedure and Patient Information

2021 Medicare Procedure Volume

The top procedures that Dr. Paul M. Yonover, MD, FACS treated as an urologist in Chicago, IL during 2021 were urologic procedures, lab tests, blood draw and minimally invasive procedures.

Volume of procedures performed by Dr. Paul M. Yonover, MD, FACS for Medicare patients.

blood draw	296
diagnostic procedures	14
doctor visit	871
hormone therapy	41
hospital care	12
inpatient care	12
lab tests	348
minimally invasive procedures	67
minor procedures	14
potassium test	15
urologic procedures	505

2021 Medicare Patient Data

Information about Medicare patients treated by Dr. Paul M. Yonover, MD, FACS.

**Gender**
Male	412
Female	31

**Ethnicity**
Non-Hispanic White	286
Black	80
Hispanic	36
Asian	0
Other	28
Native American	0

**Age**
From 65 to 74	233
From 75 to 84	156
85 and over	26
Less than 65	28

Conditions of Medicare patients treated by Dr. Paul M. Yonover, MD, FACS in 2021

Hypertension	65
High Cholesterol	57
Stroke	4
Ischemic Heart Disease	35
Depression	17
Chronic Kidney Disease	30
Asthma	6
Osteoperosis	4
Atrial Fibrilation	9
Heart Failure	14
Chronic Obstructive Pulmonary Disease	12
Diabetes	26
Dementia	9
Cancer	33

Medicare Procedure and Patient Information

2022 Medicare Procedure Volume

The top procedures that Dr. Paul M. Yonover, MD, FACS treated as an urologist in Chicago, IL during 2022 were urologic procedures, blood draw, chronic care and lab tests.

Volume of procedures performed by Dr. Paul M. Yonover, MD, FACS for Medicare patients.

blood draw	262
chronic care	203
diagnostic procedures	26
doctor visit	727
hormone therapy	35
lab tests	200
minimally invasive procedures	147
minor procedures	26
neurostimulation	88
urologic procedures	332

2022 Medicare Patient Data

Information about Medicare patients treated by Dr. Paul M. Yonover, MD, FACS.

**Gender**
Male	383
Female	29

**Ethnicity**
Non-Hispanic White	268
Black	74
Hispanic	28
Asian	0
Other	25
Native American	0

**Age**
From 65 to 74	213
From 75 to 84	147
85 and over	31
Less than 65	21

Conditions of Medicare patients treated by Dr. Paul M. Yonover, MD, FACS in 2022

Hypertension	70
High Cholesterol	69
Stroke	5
Ischemic Heart Disease	33
Depression	16
Chronic Kidney Disease	18
Asthma	8
Osteoperosis	8
Atrial Fibrilation	13
Heart Failure	13
Chronic Obstructive Pulmonary Disease	13
Diabetes	28
Dementia	5
Cancer	39

Medicare Procedure and Patient Information

Average Medicare Procedure Volume From 2012 - 2022

Volume of procedures performed by Dr. Paul M. Yonover, MD, FACS for Medicare patients.

The highest averages for the top procedures that Dr. Paul M. Yonover, MD, FACS treated as an urologist in Chicago, IL were lab tests, urologic procedures, blood draw and chronic care.

anorectal procedures	11
blood draw	252
catheterization	43
chronic care	203
diagnostic procedures	56
doctor visit	746
hormone therapy	42
hospital care	27
inpatient care	27
lab tests	463
minimally invasive procedures	142
minor procedures	54
neurostimulation	68
pelvic imaging	25
potassium test	18
stent placement (stenting)	18
ultrasound (sonogram)	25
urologic procedures	413

Average Medicare Patient Data From 2012 - 2022

Information about Medicare patients treated by Dr. Paul M. Yonover, MD, FACS.

**Gender**
Male	364
Female	41

**Ethnicity**
Black / African American	70
Asian / Pacific Islander	0
Non-Hispanic White	272
Native American / Alaskan Native	0
Hispanic	33
Other	8

**Age**
75 to 84	123
85 and over	35
Less than 65	24
65 to 74	223

Average of Total of Conditions of Medicare patients treated by Dr. Paul M. Yonover, MD, FACS From 2012 - 2022

The highest averages of the most common conditions of Medicare patients that Dr. Paul M. Yonover, MD, FACS treated were hypertension, high cholesterol, cancer and ischemic heart disease.

Hypertension	57
High Cholesterol	47
Stroke	3
Ischemic Heart Disease	29
Depression	15
Chronic Kidney Disease	25
Asthma	5
Osteoporosis	5
Heart Failure	13
Chronic Obstructive Pulmonary Disease	9
Diabetes	25
Atrial Fibrillation	9
Dementia	8
Cancer	31

Education & Training

Dr. Paul M. Yonover, MD, FACS graduated from Mount Sinai School of Medicine. He completed residency at Loyola University Affiliated Hospitals. He is certified by the The American Board of Urology - Urology and has a state license in Illinois.

Medical School: Mount Sinai School of Medicine

Residency: Loyola University Affiliated Hospitals

Board Certification: The American Board of Urology - Urology

Licensed In: Illinois

Affiliations & Hospitals

Dr. Paul M. Yonover, MD, FACS is associated with these hospitals and organizations:

Advocate Health Care

Northwestern Medicine

UroPartners

Ascension

Ascension Saint Joseph - Chicago

UroPartners

Insurance Information

Please note: Insurance information may change at any time, and the provider may accept your insurance plan even if it is not listed below. Please contact the provider's office to confirm that your insurance is accepted.

Dr. Paul M. Yonover, MD, FACS appears to accept the following insurance providers: CIGNA Choice Fund PPO, United Healthcare Select Plus POS, United Healthcare Select HMO, United Healthcare Select EPO, United Healthcare Options PPO, United Healthcare Indemnity, Aetna POS, Aetna QPOS, TRICARE Prime, Aetna Open Choice PPO, Aetna Open Access HMO, Aetna Medicare HMO, Golden Rule, TRICARE, Coventry, Aetna Open Access Aetna Select, Aetna Select, Aetna EPO, Aetna HMO, Blue Advantage PPO, Aetna Medicare PPO, United Healthcare Select Plus HMO, United Healthcare Choice Plus PPO, AARP, Medicare Advantage, Humana Medicare Choice PPO, United Healthcare Choice Plus HMO, Blue Cross PPO, Blue Advantage HMO, Blue Cross Medicare Advantage PPO, Coventry PPO, United Healthcare, Medicaid, Humana, Cigna, United Healthcare Navigate HMO, First Health, HealthLink PPO, HFN EPO, HFN PPO, HFN Platinum EPO, HFN, PHCS PPO, MultiPlan PPO, SEIU - Local 4 PPO, Union Medical (Local 1546) HMO, Aetna Medicare Prime HMO-POS, Union Medical Care PPO, Aetna Elect Choice HMO (includes Aetna Health Funds), AAH UMR Select - Team Member Plan, Aetna Medicare POS, Aetna State of Illinois Open Access Plus, Aetna Open Choice POS, Health Services and Technology, HST Care Connect PPO, Aetna Open Choice PPO - State of Illinois - SOI, United Surest (previously Bind), Aetna Managed Choice (MC) POS, Union Health Services, Inc., Aetna Open Choice POS II, Aetna State of Illinois PPO, Aetna Health Network Option, Health Services and Technology, HST Care Connect EPO, AAH UMR Preferred - Team Member Plan, Aetna Signature Administrators PPO (ASA or SRC) PPO, Aetna Upfront Advantage, Aetna Signature Administrators PPO, SEIU - Local 4 HMO, Aetna Open Access Elect Choice (includes Aetna Health Funds), Aetna NAP - PPO, Aetna Value Performance Network, Aetna Premier Care Plus Network, Blue Cross Community MMAI, BlueCare Direct HMO, Aetna Health Network Only, Aetna Premier Care Network, Blue Cross Medicare Supplement PPO and SIHO PPO.

Insurance Accepted by Provider includes:

According to our sources, Dr. Paul M. Yonover, MD, FACS accepts the following insurance providers:

CIGNA Choice Fund PPO

United Healthcare Select Plus POS

United Healthcare Select HMO

United Healthcare Select EPO

United Healthcare Options PPO

United Healthcare Indemnity

Aetna POS

Aetna QPOS

TRICARE Prime

Aetna Open Choice PPO

Aetna Open Access HMO

Aetna Medicare HMO

Golden Rule

TRICARE

Coventry

Aetna Open Access Aetna Select

Aetna Select

Aetna EPO

Aetna HMO

Blue Advantage PPO

Aetna Medicare PPO

United Healthcare Select Plus HMO

United Healthcare Choice Plus PPO

AARP

Medicare Advantage

Humana Medicare Choice PPO

United Healthcare Choice Plus HMO

Blue Cross PPO

Blue Advantage HMO

Blue Cross Medicare Advantage PPO

Coventry PPO

United Healthcare

Medicaid

Humana

Cigna

United Healthcare Navigate HMO

First Health

HealthLink PPO

HFN EPO

HFN PPO

HFN Platinum EPO

HFN

PHCS PPO

MultiPlan PPO

SEIU - Local 4 PPO

Union Medical (Local 1546) HMO

Aetna Medicare Prime HMO-POS

Union Medical Care PPO

Aetna Elect Choice HMO (includes Aetna Health Funds)

AAH UMR Select - Team Member Plan

Aetna Medicare POS

Aetna State of Illinois Open Access Plus

Aetna Open Choice POS

Health Services and Technology, HST Care Connect PPO

Aetna Open Choice PPO - State of Illinois - SOI

United Surest (previously Bind)

Aetna Managed Choice (MC) POS

Union Health Services, Inc.

Aetna Open Choice POS II

Aetna State of Illinois PPO

Aetna Health Network Option

Health Services and Technology, HST Care Connect EPO

AAH UMR Preferred - Team Member Plan

Aetna Signature Administrators PPO (ASA or SRC) PPO

Aetna Upfront Advantage

Aetna Signature Administrators PPO

SEIU - Local 4 HMO

Aetna Open Access Elect Choice (includes Aetna Health Funds)

Aetna NAP - PPO

Aetna Value Performance Network

Aetna Premier Care Plus Network

Blue Cross Community MMAI

BlueCare Direct HMO

Aetna Health Network Only

Aetna Premier Care Network

Blue Cross Medicare Supplement PPO

SIHO PPO

Ratings & Reviews

Dr. Paul M. Yonover, MD, FACS has an exceptional overall rating with an average of 4.89 out of 5 stars based on 326 ratings. We collect ratings and reviews of Dr. Paul M. Yonover, MD, FACS from all over the web to help you find the right in Chicago, IL.

4.89

Overall Rating

(326 Ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. Paul M. Yonover, MD, FACS. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
Astellas Pharma US Inc	$39,096 Myrbetriq $26,784	XTANDI $8,955	Vesicare $247	Mirabegron $217	$2,893
Augmenix, Inc.	$24,611 SpaceOAR $24,611
Pfizer Inc.	$10,313 XTANDI $10,231	TOVIAZ $46	VIAGRA $25	SUTENT $11
ACCORD HEALTHCARE, INC.	$10,166 CAMCEVI $10,166
Bayer HealthCare Pharmaceuticals Inc.	$6,858 Xofigo $6,086	Nubeqa $772
Other	$23,715 ILLUCCIX $5,901	ZYTIGA $3,378	Rubraca $2,509	PYLARIFY $2,222	Axumin $1,138	Other $8,567

**Types of Payments**
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program	$42,855
Consulting Fee	$42,157
Food and Beverage	$13,132
Travel and Lodging	$10,730
Honoraria	$5,550
Other	$334

Research Payments

Dr. Paul M. Yonover, MD, FACS has received 5 research payments totaling $30,236.

Ownership and Interest Payments

This table describes ownership payments received by Dr. Paul M. Yonover, MD, FACS.

UroGPO LLC	2020	$84,936.38	Physician Covered Recipient	Common Stock
UroGPO LLC	2017	$79,961.50	Physician Covered Recipient	Common Stock
UroGPO LLC	2019	$37,124.34	Physician Covered Recipient	Common Stock
SN Holdings, LLC	2022	$35,673.26	Physician Covered Recipient	Common Stock
UroGPO LLC	2018	$34,083.98	Physician Covered Recipient	Common Stock
SN Holdings, LLC	2021	$33,125.17	Physician Covered Recipient	Common Stock
UroGPO LLC	2016	$3,729.00	Physician Covered Recipient	Common Stock
UroGPO LLC	2015	$2,000.00	Physician Covered Recipient	Common Stock
UroGPO LLC	2014	$2,000.00	Physician Covered Recipient	Common Stock
UroGPO LLC	2013	$0.00	Physician Covered Recipient	Common Stock

Biography

Dr. Paul Yonover's area of specialization is urology (urinary tract disease). His average rating from his patients is 5.0 stars (out of 5). His areas of expertise consist of benign prostatic hyperplasia (enlarged prostate), kidney stones, and testicular cancer. Dr. Yonover usually honors Aetna EPO, Blue California, and Coventry, in addition to other insurance carriers. Dr. Yonover's education and training includes medical school at Mount Sinai School of Medicine and residency at a hospital affiliated with Loyola University. His distinctions include: Castle Connolly Regional Top Doctors: 1st Edition; Chicago Magazine's Top Cancer Doctors in Chicago; and Chicago Magazine's Top Doctors in Chicago. He is conversant in Spanish. His hospital/clinic affiliations include UroPartners, Northwestern Medicine, and Advocate Condell Medical Center.